84. サルコイドーシス Sarcoidosis Clinical trials / Disease details
臨床試験数 : 149 / 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01324999 (ClinicalTrials.gov) | March 2011 | 24/3/2011 | Tadalafil for Sarcoidosis Associated Pulmonary Hypertension | Tadalafil for Sarcoidosis Associated Pulmonary Hypertension | Pulmonary Hypertension | Drug: Tadalafil | University of North Carolina, Chapel Hill | Eli Lilly and Company;United Therapeutics;University of Cincinnati | Completed | 18 Years | N/A | All | 12 | Phase 2/Phase 3 | United States |